Healthy young people might not get the coronavirus vaccine until 2022 as public health officials focus on immunizing the elderly and other vulnerable groups first, top officials from the World Health Organization said Wednesday. Researchers have been warning that production constraints and hoarding could limit SARS-CoV-2 vaccine supplies. This warningContinue Reading

An organization aims to compare “apples to apples” and analyze data from all of the experimental drugs that reach clinical trials to determine which COVID-19 vaccine candidates have the best chances of beating the virus.The Coalition for Epidemic Preparedness Innovations (CEPI), which is funding in part some of the vaccinesContinue Reading

CNBC interviewed five participants — three in Moderna’s study and two in Pfizer’s late-stage trials — about their symptoms after getting vaccinated. While the symptoms were uncomfortable, and at times intense, they often went away after a day, sometimes sooner, according to three participants in the Moderna trial and one in Pfizer’sContinue Reading